Skin Cancer/Melanoma

Latest News

FDA Approval
FDA Grants Accelerated Approval to Retifanlimab for Locally Advanced Merkel Cell Carcinoma

March 22nd 2023

Retifanlimab has received accelerated approved for patients with metastatic or recurrent, locally advanced merkel cell carcinoma.

melanoma
Caressa Valdueza Highlights Best Practices for the Management of Common Adverse Events in Melanoma

December 30th 2022

melanoma
RP1 Plus Nivolumab Generates Activity in Pretreated Cutaneous Melanoma

December 23rd 2022

Nurse Navigation
APRN-Led Discharge Program Reduces Readmission Rates Following Treatment With Immune Checkpoint Inhibitors

December 20th 2022

Atezolizumab Gets Green Light in Alveolar Soft Part Sarcoma
Atezolizumab Gets Green Light in Alveolar Soft Part Sarcoma

December 13th 2022

Video Interviews
Podcasts
Oncology Nursing News
Key Advances in Cancer Survivorship Toxicity Management

More News

© 2023 MJH Life Sciences

All rights reserved.